The EMA’s Committee for Medicinal Products for Human Use (CHMP) has issued its recommended conditions for compassionate use of Gilead’s antiviral remdesivir for treatment of COVID-19. Read More

German researchers will soon begin testing a potential COVID-19 vaccine based on an old tuberculosis vaccine. Read More

Pfizer, Eli Lilly and Merck are allowing their employees who are licensed medical professionals to volunteer in COVID-19 medical efforts. Read More

Drugmakers are scouring their product portfolios for possible COVID-19 treatments and some are showing potential. Read More

The FDA is promoting a nationwide effort to investigate two blood-based therapies for treatment of COVID-19. Read More

The companies said they will finalize the financial details in the coming weeks. Read More

The anti-malaria drug hydroxychloroquine was effective in treating COVID-19 patients in China, according to early data from a small clinical trial. Read More

Philip Morris and British American Tobacco (BAT) have entered the race for a COVID-19 vaccine in collaboration with two biotech firms working on plant-based vaccines. Read More